Related Experiment Videos
Benzene toxicity and risk assessment, 1972-1992: implications for future regulation
D J Paustenbach1, R D Bass, P Price
1McLauren/Hart Environmental Engineering, ChemRisk Division, Alameda, CA 94062.
Environmental Health Perspectives
|December 1, 1993
Summary
Chronic benzene exposure, particularly at high levels, is linked to acute myelogenous leukemia (AML). Risk assessment models are crucial for predicting health risks from lower benzene exposures in communities and workplaces.
Area of Science:
- Environmental Health
- Toxicology
- Epidemiology
Background:
- Benzene vapor exposure presents significant human health risks.
- Risk assessment methods are essential for evaluating the probability of adverse health effects from specific exposure levels.
- Understanding benzene's leukemogenic potential is critical for public health.
Purpose of the Study:
- To review and evaluate benzene risk assessments conducted over the past 20 years.
- To assess the evidence linking benzene exposure to various types of leukemia.
- To identify appropriate models for predicting human cancer risk from low-dose benzene exposure.
Main Methods:
- Review of published literature on benzene exposure and health effects.
- Evaluation of various risk assessment methodologies, including linear-quadratic and conditional logistic models.
- Analysis of major epidemiology studies, with a focus on the Pliofilm cohort.
Main Results:
- Sufficient evidence indicates chronic, high-level benzene exposure increases the incidence of acute myelogenous leukemia (AML).
- Evidence for benzene causing other leukemias is inconclusive due to inconsistent study results.
- The Pliofilm cohort is considered the most reliable for estimating cancer potency due to robust exposure and disease data.
Conclusions:
- Benzene's link to AML is well-established, necessitating accurate risk assessment.
- Linear-quadratic and conditional logistic models are suitable for predicting cancer risk within common environmental and occupational exposure ranges (1 ppb to 10 ppm).
- Current regulatory cancer potency estimates by EPA, OSHA, and ACGIH rely heavily on the Pliofilm cohort data.